Your shopping cart is currently empty

CLT-28643 is a potent and specific α5β1-Integrin inhibitor that prevents fibrosis in glaucoma filtration surgery (GFS), inhibits tumor growth and angiogenesis, suppresses fibrosis and inflammation in a bleomycin-induced lung fibrosis model, and improves insulin sensitivity and cardiac function in H9C2 cells from obese mice.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $293 | - | In Stock | |
| 5 mg | $722 | - | In Stock | |
| 10 mg | $987 | - | In Stock | |
| 25 mg | $1,520 | - | In Stock | |
| 50 mg | $1,980 | - | In Stock | |
| 100 mg | $2,500 | - | In Stock |
| Description | CLT-28643 is a potent and specific α5β1-Integrin inhibitor that prevents fibrosis in glaucoma filtration surgery (GFS), inhibits tumor growth and angiogenesis, suppresses fibrosis and inflammation in a bleomycin-induced lung fibrosis model, and improves insulin sensitivity and cardiac function in H9C2 cells from obese mice. |
| In vitro | In H9C2 cardiomyocytes, CLT-28643 (3 hours) was used to assess its effect on insulin signaling under metabolic stress, CLT-28643 prevented high glucose and palmitate-induced insulin resistance by significantly increasing the phosphorylated Akt (Ser473) to total Akt ratio, indicating restored insulin sensitivity. [1] |
| In vivo | In male C57BL/6 mice fed a high-fat-high-sucrose (HFHS) diet for 10 weeks, CLT-28643 (75 mg/kg; oral gavage; twice daily for 4 weeks) was administered to evaluate its cardiometabolic effect. CLT-28643 improved cardiac function by reversing the HFHS diet-induced elevation in heart rate, suggesting enhanced cardiovascular performance. [1] |
| Synonyms | CLT28643 |
| Molecular Weight | 351.36 |
| Formula | C19H17N3O4 |
| Cas No. | 1153631-91-4 |
| Smiles | O=C(O)C1=CN=C2C=CC(=CC2=C1NC3=CC=C(OC)C=C3)C(=O)NC |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.